Description:

Ultrasound soft markers and serum screening have been the basis of non-invasive aneuploidy risk assessment for many years. The role of ultrasound soft markers in prenatal screening has evolved with the advent of cell-free DNA (cfDNA) testing. This presentation will review the latest recommendations regarding soft markers and NIPT.